Trials / Unknown
UnknownNCT04264975
Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, single-center, non-randomized clinical trial on utilization of microbiome as biomarkers and therapeutics in immuno-oncology. This research consists of two parts: part 1: development of microbiome biomarkers for immuno-oncology part 2: proof-of-concept trial on the fecal microbiota transplantation in patients who are being treated with immunotherapy for advanced solid tumor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | fecal microbiota transplantation | Fecal microbiota transplantation (FMT) is the administration of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient's microbial composition and confer a health benefit |
Timeline
- Start date
- 2018-06-04
- Primary completion
- 2022-04-30
- Completion
- 2023-04-30
- First posted
- 2020-02-11
- Last updated
- 2020-02-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04264975. Inclusion in this directory is not an endorsement.